Similar to Foxp3 expression, SLN from breast cancer patients contained higher numbers of IDO producing cells; however, the difference between cancer and control patients was not statistically significant, and IDO expression did not predict nodal status in a regression analysis. This evidence concerns the gene FOXP3 and breast cancer.